Mereo BioPharma Group plc (MREO) Cash Flow Quarterly - Discounting Cash Flows
MREO
Mereo BioPharma Group plc
MREO (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
Report Filing: 2025-11-10 2025-11-10 2025-08-12 2025-05-13 2025-03-26 2024-11-12 2024-08-13
1234
Net Income/Starting Line -41.57 -7.02 -14.62 -12.89 -7.05 -15 -12.26
1234
Cash From Operating Activities -32.71 -7.31 -7.65 -8.33 -9.42 -7.52 -7.9
1234
Depreciation and Amortization 0.831 -0.011 0.298 0.27 0.274 0.282 0.257
1234
Deferred Income Tax 0 0 0 0 0 0 0
1234
Stock Based Compensation 5.86 0 2.06 2.28 1.51 1.74 2.09
1234
Other Non-Cash Items 2.04 -0.91 5.45 2.52 -5.02 6.84 0.586
1234
Changes in Working Capital 0.136 0.636 -0.843 -0.514 0.857 -1.38 1.42
1234
Accounts Receivable -0.368 0 -0.744 0.952 -0.576 -0.226 0
1234
Inventory 0 0 0 0 0 0 0
1234
Accounts Payable -0.746 0 -1.95 0.362 0.843 -1.06 0
1234
Deferred Revenue 1.25 0.636 1.85 -1.83 0.59 -0.09 1.42
1234
Other Working Capital 0 0 0 0 0 0 0
1234
Cash From Investing Activities -0.02 0.3 0 -0.32 0 0 0.001
1234
Investments in Property Plant and Equipment -0.02 0 0 -0.02 0 0 0
1234
Payments for Acquisitions 0 0 0 0 0 0 0
1234
Purchases of Securities 0 0 0 0 0 0 0
1234
Sales and Maturities of Investments 0 0 0 0 0 0 0
1234
Other Investing Activities 0 0.3 0 -0.3 0 0 0.001
1234
Cash From Financing Activities 0.248 0 -0.134 0.422 -0.04 -0.594 46.78
1234
Debt Repayment 0 0 0 0 0 0 0
1234
Common Stock Issued 0 0 0 0 0 0 0
1234
Common Stock Repurchased 0 0 0 0 0 0 0
1234
Dividends Paid 0 0 0 0 0 0 0
1234
Other Financing Activities 0.248 0 -0.134 0.422 -0.04 -0.594 46.78
1234
Effect of Forex Changes on Cash 0.657 -0.418 1.43 0.908 -1.26 1.2 -0.107
1234
Net Change in Cash -21.1 -7.43 -6.36 -7.32 -10.72 -6.91 38.77
1234
Cash at Beginning of Period 69.8 56.12 62.48 69.8 80.52 87.43 48.66
1234
Cash at End of Period 48.7 48.7 56.12 62.48 69.8 80.52 87.43
1234
Free Cash Flow -33.03 -7.31 -7.65 -8.65 -9.42 -7.52 -7.9
1234
Operating Cash Flow -32.71 -7.31 -7.65 -8.33 -9.42 -7.52 -7.9
1234
Capital Expenditure -0.32 0 0 -0.32 0 0 0
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program